- Polyethylene glycol (PEG) masks particles from immune recognition preventing uptake by liver and spleen
- Nanoparticles exit circulatory system only at the tumor neovasculature due to leakiness of blood vessels
- Particles too large to exit circulation elsewhere
- TNF targeting molecule on particle’s surface binds to receptors causing vascular disruption in and around tumor sites.